/Investor DB

Flagship Pioneering — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Quotient Therapeuticsquotient-tx.comin𝕏Seed · Nov 2023 · $50M✓ verified

Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform.

AI & Machine LearningBiotechDeep Tech

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Empress TherapeuticsL Nutra

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.